Within two to four weeks we find potential targets/biomarker candidates or do a detailed target/biomarker assessment. This will save you months of painstaking on-line desk research. Enter your contact details and we’ll contact you to discuss next steps.

Use our platform to find novel target/biomarker candidates or do detailed target/biomarker assessment yourselves. This will save you months of painstaking on-line desk research. Enter your contact details and we’ll set up a demo to show you!

Please contact me to discuss:

Subscription to Euretos AI Platform
Euretos consulting service
Direct access to Euretos API

Do you have a question on gene-disease associations that are not covered on this page? Or would you like to know more about the Euretos AI Platform? Please fill in your contact details and we will reach out to you!

Euretos AI pilot with Elsevier makes top 10 list of most viewed stories of 2018

Friday 11 January 2019

Elsevier Connect, the news site of Elsevier, recently announced that the Euretos AI Pilot with Elsevier was one of the top 10 of most viewed news articles for 2018.

The Elsevier Connect site received nearly 2.6 million views in 2018. The site features daily stories for the global science, health and technology communities. It explores the complex and ever-evolving worlds of science and publishing, with topics ranging from trends in research to new discoveries, publishing tips, and how technology is transforming the way we work.

The AI pilot with Elsevier was announced on the 2nd of February 2018 and aimed to enrich scientific publications with hypotheses that are generated using the Euretos AI Platform. The pilot ran in collaboration with the International Journal of Biochemistry and Cell Biology (IJBCB). Focusing on an open question in an article’s discussion section, a hypothesis is created and discussed in a dedicated discussion group on Mendeley. The aim of the pilot is to assess whether these AI derived hypotheses can provide a catalyst for further scholarly discussion.

Read more about the collaboration on Elsevier Connect.